Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains
Abstract The burden of antibiotic resistance is currently estimated by mathematical modeling, without real count of resistance to key antibiotics. Here we report the real rate of resistance to key antibiotics in bacteria isolated from humans during a 5 years period in a large area in southeast in Fr...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca09e31701954a30a0083ebb365562f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ca09e31701954a30a0083ebb365562f1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ca09e31701954a30a0083ebb365562f12021-12-02T15:09:57ZMajor discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains10.1038/s41598-020-75158-72045-2322https://doaj.org/article/ca09e31701954a30a0083ebb365562f12020-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-75158-7https://doaj.org/toc/2045-2322Abstract The burden of antibiotic resistance is currently estimated by mathematical modeling, without real count of resistance to key antibiotics. Here we report the real rate of resistance to key antibiotics in bacteria isolated from humans during a 5 years period in a large area in southeast in France. We conducted a retrospective study on antibiotic susceptibility of 539,107 clinical strains isolated from hospital and private laboratories in south of France area from January 2014 to January 2019. The resistance rate to key antibiotics as well as the proportion of bacteria classified as Difficult-to-Treat (DTR) were determined and compared with the Mann–Whitney U test, the χ2 test or the Fisher’s exact test. Among 539,037 isolates, we did not observe any significant increase or decrease in resistance to key antibiotics for 5 years, (oxacillin resistance in Staphylococcus aureus, carbapenem resistance in enterobacteria and Pseudomonas aeruginosa and 3rd generation cephalosporin resistance in Escherichia coli and Klebsiella pneumoniae). However, we observed a significant decrease in imipenem resistance for Acinetobacter baumannii from 2014 to 2018 (24.19–12.27%; p = 0.005) and a significant increase of ceftriaxone resistance in Klebsiella pneumoniae (9.9–24.03%; p = 0.001) and Enterobacter cloacae (24.05–42.05%; p = 0.004). Of these 539,037 isolates, 1604 (0.3%) had a DTR phenotype. Over a 5-year period, we did not observe a burden of AR in our region despite a high rate of antibiotic consumption in our country. These results highlight the need for implementation of real-time AR surveillance systems which use factual data.Ousmane Oumou DialloSophie Alexandra BaronGregory DubourgHervé ChaudetPhilippe HalfonSabine CamiadeBéatrice ComteStéphanie JoubertArnaud FrançoisPhilippe SeyralFrançois ParisotJean-Paul CasaltaRaymond RuimyChristophe MaruejoulsJean-Christophe AchiardySophie BurignatJoseph CarvajalEdouard DelaunaySandra MeyerPierre-Yves LevyPatricia RoussellierPatrick BrunetClaude BosiPhilippe StolidiJean-Pierre ArzouniGisele GayPierre HancePhilippe ColsonDidier RaoultJean-Marc RolainNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-9 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ousmane Oumou Diallo Sophie Alexandra Baron Gregory Dubourg Hervé Chaudet Philippe Halfon Sabine Camiade Béatrice Comte Stéphanie Joubert Arnaud François Philippe Seyral François Parisot Jean-Paul Casalta Raymond Ruimy Christophe Maruejouls Jean-Christophe Achiardy Sophie Burignat Joseph Carvajal Edouard Delaunay Sandra Meyer Pierre-Yves Levy Patricia Roussellier Patrick Brunet Claude Bosi Philippe Stolidi Jean-Pierre Arzouni Gisele Gay Pierre Hance Philippe Colson Didier Raoult Jean-Marc Rolain Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
description |
Abstract The burden of antibiotic resistance is currently estimated by mathematical modeling, without real count of resistance to key antibiotics. Here we report the real rate of resistance to key antibiotics in bacteria isolated from humans during a 5 years period in a large area in southeast in France. We conducted a retrospective study on antibiotic susceptibility of 539,107 clinical strains isolated from hospital and private laboratories in south of France area from January 2014 to January 2019. The resistance rate to key antibiotics as well as the proportion of bacteria classified as Difficult-to-Treat (DTR) were determined and compared with the Mann–Whitney U test, the χ2 test or the Fisher’s exact test. Among 539,037 isolates, we did not observe any significant increase or decrease in resistance to key antibiotics for 5 years, (oxacillin resistance in Staphylococcus aureus, carbapenem resistance in enterobacteria and Pseudomonas aeruginosa and 3rd generation cephalosporin resistance in Escherichia coli and Klebsiella pneumoniae). However, we observed a significant decrease in imipenem resistance for Acinetobacter baumannii from 2014 to 2018 (24.19–12.27%; p = 0.005) and a significant increase of ceftriaxone resistance in Klebsiella pneumoniae (9.9–24.03%; p = 0.001) and Enterobacter cloacae (24.05–42.05%; p = 0.004). Of these 539,037 isolates, 1604 (0.3%) had a DTR phenotype. Over a 5-year period, we did not observe a burden of AR in our region despite a high rate of antibiotic consumption in our country. These results highlight the need for implementation of real-time AR surveillance systems which use factual data. |
format |
article |
author |
Ousmane Oumou Diallo Sophie Alexandra Baron Gregory Dubourg Hervé Chaudet Philippe Halfon Sabine Camiade Béatrice Comte Stéphanie Joubert Arnaud François Philippe Seyral François Parisot Jean-Paul Casalta Raymond Ruimy Christophe Maruejouls Jean-Christophe Achiardy Sophie Burignat Joseph Carvajal Edouard Delaunay Sandra Meyer Pierre-Yves Levy Patricia Roussellier Patrick Brunet Claude Bosi Philippe Stolidi Jean-Pierre Arzouni Gisele Gay Pierre Hance Philippe Colson Didier Raoult Jean-Marc Rolain |
author_facet |
Ousmane Oumou Diallo Sophie Alexandra Baron Gregory Dubourg Hervé Chaudet Philippe Halfon Sabine Camiade Béatrice Comte Stéphanie Joubert Arnaud François Philippe Seyral François Parisot Jean-Paul Casalta Raymond Ruimy Christophe Maruejouls Jean-Christophe Achiardy Sophie Burignat Joseph Carvajal Edouard Delaunay Sandra Meyer Pierre-Yves Levy Patricia Roussellier Patrick Brunet Claude Bosi Philippe Stolidi Jean-Pierre Arzouni Gisele Gay Pierre Hance Philippe Colson Didier Raoult Jean-Marc Rolain |
author_sort |
Ousmane Oumou Diallo |
title |
Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
title_short |
Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
title_full |
Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
title_fullStr |
Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
title_full_unstemmed |
Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
title_sort |
major discrepancy between factual antibiotic resistance and consumption in south of france: analysis of 539,037 bacterial strains |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/ca09e31701954a30a0083ebb365562f1 |
work_keys_str_mv |
AT ousmaneoumoudiallo majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT sophiealexandrabaron majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT gregorydubourg majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT hervechaudet majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT philippehalfon majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT sabinecamiade majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT beatricecomte majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT stephaniejoubert majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT arnaudfrancois majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT philippeseyral majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT francoisparisot majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT jeanpaulcasalta majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT raymondruimy majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT christophemaruejouls majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT jeanchristopheachiardy majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT sophieburignat majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT josephcarvajal majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT edouarddelaunay majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT sandrameyer majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT pierreyveslevy majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT patriciaroussellier majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT patrickbrunet majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT claudebosi majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT philippestolidi majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT jeanpierrearzouni majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT giselegay majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT pierrehance majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT philippecolson majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT didierraoult majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains AT jeanmarcrolain majordiscrepancybetweenfactualantibioticresistanceandconsumptioninsouthoffranceanalysisof539037bacterialstrains |
_version_ |
1718387778832564224 |